Managers / Q4 2020 · view latest →
Minot Wealth Management LLC
CIK 0001801774 · 690 CANTON STREET, SUITE 245, WESTWOOD, MA, 02090 · (978) 226-4668
Summary
Minot Wealth Management LLC reported $335M in U.S.-listed holdings across 158 positions for Q4 2020.
Its largest position, AAPL, represents 5.1% of the portfolio.
Compared with Q3 2020, the fund opened 25 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 72.9% · $244M
- ETP · 19.9% · $67M
- Other · 4.2% · $14M
- REIT · 1.7% · $6M
- ADR · 1.1% · $4M
- Other · 0.1% · $385,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| INNOVATIVE INDL PPTYS INC | NEW | +16.8K | 16.8K | +$3M | $3M |
| CRWDCROWDSTRIKE HLDGS INC | NEW | +13.9K | 13.9K | +$3M | $3M |
| VRMUSDVROOM INC | NEW | +58.8K | 58.8K | +$2M | $2M |
| BROOKFIELD RENEWABLE PARTNER | NEW | +39.0K | 39.0K | +$2M | $2M |
| ADSKAUTODESK INC | NEW | +3.1K | 3.1K | +$961,000 | $961,000 |
| CAHCARDINAL HEALTH INC | NEW | +16.0K | 16.0K | +$854,000 | $854,000 |
| ARDSARIDIS PHARMACEUTICALS INC | NEW | +132.3K | 132.3K | +$803,000 | $803,000 |
| ISRGINTUITIVE SURGICAL INC | NEW | +606 | 606 | +$496,000 | $496,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2022 | $389M | 185 | Jul 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $464M | 204 | Apr 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $519M | 204 | Jan 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $463M | 205 | Oct 25, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $458M | 204 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $392M | 200 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $335M | 158 | Jan 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $265M | 142 | Oct 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $200M | 113 | Jul 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $140M | 104 | Apr 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $219M | 134 | Feb 5, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.